# Savantus Ventures

> Savantus Ventures is a VC fund in Nyack backing Biotechnology and Health Care. See 12 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Nyack, United States
- Total investments: 12
- Last investment: Sep 2025
- Lead investor: 8%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/SavantusVC
- Website: http://savantusventures.com/

Savantus Ventures is a VC fund in Nyack focused on Biotechnology and Health Care. Savantus Ventures invest in high-potential seed-stage teams.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 50% |
| Health Care | 3 | 25% |
| Medical | 2 | 17% |
| FinTech | 1 | 8% |
| Finance | 1 | 8% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 50% |
| Pre-Seed | 3 | 25% |
| Series A | 1 | 8% |
| Funding Round | 1 | 8% |
| Convertible Note | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 50% |
| Canada | 1 | 8% |
| United Kingdom | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Scindo | Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternativeto landfills and incineration. | $5.4M | Seed | Sep 23, 2025 |  |
| Taxa Technologies | Designer probiotics for personal care | $2.5M | Pre-Seed | Feb 16, 2024 |  |
| SFA Therapeutics | SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4.5M |  | Nov 09, 2023 |  |
| SFA Therapeutics | SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4.5M | Convertible Note | Nov 09, 2023 |  |
| Liberum Biotech | Liberum offers next generation protein manufacturing. Taking advantage of our suite of proprietary molecular and hardware technologies, we bring speed, scalability and cost reduction to disrupt current biologics manufacturing practices. Our vision is to democratize access to the fruits of synthetic biology. | $1.8M | Seed | Jul 24, 2023 |  |
| Siren Biotechnology | Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transformshow tumor cells are eliminated and anti-tumor immunity is stimulated. |  | Seed | May 17, 2023 |  |
| SFA Therapeutics | SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs. | $4M | Seed | Jun 20, 2022 |  |
| Capra Biosciences | Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processingrequirements and costs inherent in the bio-manufacturing of products such as fuels.Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA. | $1.8M | Pre-Seed | Jun 06, 2022 |  |
| Scindo | Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternativeto landfills and incineration. | $1M | Pre-Seed | Apr 28, 2022 |  |
| Enter | Enter is a payments platform for the world's leading emerging market businesses. | $5.7M | Seed | Mar 08, 2022 |  |

10 of 12 investments shown.

## Co-investors
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 6 deals together
- [Asymmetry Ventures](https://shizune.co/investors/profile/asymmetry-ventures) — VC Fund, 5 deals together
- [Farvatn Venture](https://shizune.co/investors/profile/planet-9-capital) — VC Fund, 5 deals together
- [SynBioVen](https://shizune.co/investors/profile/synbioven) — VC Fund, 4 deals together
- [North South Ventures](https://shizune.co/investors/profile/north-south-ventures) — VC Fund, 3 deals together
- [AgFunder](https://shizune.co/investors/profile/agfunder) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Savantus Ventures invest in?

Savantus Ventures invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Pre-Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Savantus Ventures last invest?

The most recent investment recorded for Savantus Ventures closed in Sep 2025. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co